The Signature Topical Cream THC Level reflects a moderate THC range that supports a balanced experience. Signature Topical Cream Strain presents a measured potency profile that aligns with balanced enjoyment. The cannabinoid profile stays consistent from start to finish and supports a clean progression of effects.
Signature Topical Cream Strain Effects are listed below.
CBD, a primary active ingredient, interacts with skin receptors to promote relief and soothe irritation, supporting localized comfort.
DMSO acts as a carrier agent, increasing the absorption of active ingredients for deeper penetration and efficient results.
Hemp Seed Oil provides moisturizing properties, supporting skin hydration and maintaining the skin’s natural barrier.
Aloe Vera Extract offers soothing and cooling effects, helping to calm irritated skin and promote relief.
Vitamin E functions as an antioxidant, protecting the skin from oxidative stress and supporting its overall health.
Menthol provides a cooling sensation, which helps to alleviate irritation and refresh the skin.
The Signature Topical Cream strain effects are designed to work synergistically, supporting skin health and providing a soothing, hydrating experience.
Signature Topical Cream Strain presents a terpene profile defined by a clean, subtle aroma layered with hints of natural botanicals and a smooth, mild finish. The combined terpene expression creates a clear sensory identity that defines Signature Topical Cream Strain.
The Signature Topical Cream Strain Terpene Profile is listed below.
Signature Topical Cream Strain growing factors influence yield, resin, and overall quality. Proper regulation of temperature, humidity, and pH preserves flower quality and plant health.
A summary of the key growing factors for Signature Topical Cream Strain is shown in the table below.
| Signature Topical Cream Growing Factor | Description |
|---|---|
| Difficulty | The cultivation difficulty of Signature Topical Cream is typically assessed by growers. |
| Flowering Time | Signature Topical Cream exhibits a standard flowering time for its genetic profile. |
| Yield | Yields for Signature Topical Cream can vary based on growing conditions and expertise. |
| Climate | Signature Topical Cream thrives in specific environmental conditions that support its growth. |
Aroma: Signature Topical Cream releases a distinct and complex aroma profile.
Flavor: Signature Topical Cream delivers a nuanced and characteristic flavor experience.
Overall Impression: Signature Topical Cream presents a memorable and well-rounded sensory impression.
Signature Collection Topical Cream compares to other CBD topicals through its full-spectrum nano cannabinoid profile of over 1,000 mg per 1 fl oz jar, R134a extraction method, and broader cannabinoid range that includes CBD, CBDA, CBG, CBGA, CBN, D-8, D-9. The 250mg CBD Topical Cream offers a single-cannabinoid focused formula at a lower concentration, while the Signature Collection delivers over four times the cannabinoid content alongside a wider spectrum of naturally occurring hemp compounds per jar. DMSO in the Signature Collection formula acts as a carrier that supports deeper delivery of the full cannabinoid and terpene profile into the skin compared to standard cream formats without this ingredient. Advanced R134a extraction preserves the plant's natural constituents in their original form, providing a more complete plant profile than standard CO2 or solvent-based extraction methods. Proprietary nanotechnology shrinks cannabinoid particle size, which may improve bioavailability and support faster uptake through the epidermal layers. The topical cream applies smoothly, absorbs without leaving a greasy residue, and comes in a compact 1 fl oz jar at [$69.99], offering a higher cannabinoid volume per dollar compared to standard single-cannabinoid topical formats. The full-spectrum formula with terpenes, including Alpha-Pinene, Limonene, Beta-Caryophyllene, and Linalool, supports broader plant compound activity at the skin surface compared to isolate or broad-spectrum alternatives.
The cream features a subtle, natural aroma from its terpene profile, including Alpha-Pinene and Limonene, designed for a pleasant topical experience.
User Experience: Signature Topical Cream applies smoothly, absorbs without leaving a greasy residue, and a small amount spreads widely for efficient coverage.
Signature Collection Topical Cream takes 5 to 15 minutes to work on the skin after application, depending on skin type and the targeted area. Proprietary nanotechnology shrinks cannabinoid particle size, which may support faster penetration into the dermal layers compared to standard cream formats without nano-emulsification. DMSO in the formula acts as a carrier that supports deeper and more efficient delivery of active ingredients through the skin surface per session. Massaging the cream into the skin after application may further accelerate delivery through increased surface circulation at the targeted area. Thinner skin areas generally absorb cream formulas faster than thicker tissue zones found on the back or larger muscle groups. Consistent daily use leads to more predictable absorption timing with each subsequent application. A small amount of the Signature Collection cream spreads widely due to its formulation, ensuring efficient coverage per session.
A drop or two of Signature Collection Topical Cream should be applied per use to the targeted skin area provides enough coverage for most localized sessions. A small amount spreads widely across the skin surface, making the 1 fl oz jar a long-lasting supply for daily use. Users pat the cream onto the targeted area and massage gently until it fully absorbs into the skin without residue. Larger surface areas (upper back or thighs) may require a slightly larger application for full and even coverage. Rolling or patting the cream evenly across the skin surface ensures the full cannabinoid and terpene profile reaches the targeted dermal layers. Consistent quantities per session help maintain predictable cannabinoid contact at the localized skin level throughout the day. Overuse does not improve results and may leave a surface layer rather than improving localized uptake per application.
Signature Collection Topical Cream differs from CBD roll-ons through its cream-based consistency, higher 1,000 mg full-spectrum nano cannabinoid content, broader surface coverage design, and fingertip application method compared to the hands-free rolling ball delivery of compact roll-on serum formats. The CBD Topical Roll-On Serum delivers 300 mg of CBD in a compact 10 mL oil-based serum container at [$59.95], while the Signature Collection Topical Cream delivers 1,000 mg of full-spectrum nano cannabinoids in a 1 oz cream format at [$69.99], providing a significantly higher total cannabinoid concentration per container. The roll-on serum transfers product through a rotating ball mechanism that requires no direct hand contact, while the Signature Collection Topical Cream applies through fingertip pressure, allowing full control over coverage depth and massage intensity at each targeted area. Advanced R134a extraction in the Signature Collection cream preserves a broader full-spectrum cannabinoid range, including CBD, CBDA, CBG, CBGA, and trace THC at or below 0.3%, delivering a richer whole-plant formula than standard roll-on serum formats. The cream-based texture settles onto the skin differently from an oil-based serum, supporting an extended surface contact time suited for broader muscle and joint areas during each session. The CBD Topical Rolls On Serum suits active users who prioritize portability and hands-free delivery during workouts or travel, while the Signature Collection Topical Cream suits consumers seeking a higher-potency, full-spectrum cream-based formula for targeted at-home daily use.
The Signature Topical Cream is a carefully formulated product designed for external use, rather than a cannabis strain with genetic crosses or parent strains.
Verify the quality of Signature Collection Topical Cream by reviewing the independently produced third-party lab results that confirm the full spectrum cannabinoid content, nano-emulsification standards, and safety screening outcomes for each specific production batch. CBD American Shaman follows best industry standards as certified by the US Hemp Authority, requiring documented safety and quality practices across every topical formula in the product line. Hemp plants used in the cream are sourced from agriculturally responsible USA farms, and the formula uses advanced R134a extraction to maintain the plant's natural compounds throughout the production process. A Certificate of Analysis for specific batches is accessible through the lab results section of the CBD American Shaman website, allowing any consumer to confirm the full-spectrum cannabinoid profile and safety outcomes at any time. The physical container carries a UPC and batch number that correspond directly to available lab documentation, supporting full product-level traceability per individual purchase. The 1,000 mg full-spectrum nano cannabinoid content and proprietary nanotechnology are confirmed on the product page as key formulation features that distinguish the cream from standard hemp topicals. Specific batch documentation or ingredient details not available on the product page can be confirmed by contacting CBD American Shaman directly at 1-855-427-7386.
Read the CBD topical cream lab results by locating the cannabinoid profile section first and confirming that the total cannabinoid content reflects the 1,000 mg full-spectrum nano cannabinoid label printed on the 1-oz Signature Collection container. The cannabinoid column in the lab report lists measured values for each compound present in the full-spectrum formula, including CBD, CBDA, CBG, CBGA, and other naturally occurring plant cannabinoids retained through R134a extraction. The THC column confirms trace THC levels at or below 0.3%, verifying the federally compliant full-spectrum classification of this specific product. Each compound listed within the profile section shows the exact measured concentration found in that production batch, providing a complete plant compound breakdown for consumer reference. The safety section documents completed screening for residual solvents, heavy metals, pesticides, and microbial contaminants that affect the suitability of the cream for direct and repeated skin contact. A "Pass" result across every safety category confirms the batch is free from harmful substances at concentrations that pose a risk during external application. Matching the batch number printed on the physical 1 oz container to the corresponding lab report confirms that the documentation applies to the exact product received.
CBD American Shaman Signature Collection Topical Cream Certificate of Analysis showing cannabinoid profile, ND THC result, contaminant screening, and verified potency for the current production batch.
Third party testing matters for CBD topical creams because independent laboratory evaluation removes any manufacturer influence from the accuracy and integrity of reported cannabinoid content and safety data across every production batch. Independent labs assess each batch without a financial stake in the results, ensuring the findings reflect the actual full-spectrum cannabinoid composition and safety profile of every 1-oz Signature Collection Topical Cream container. The US Hemp Authority certifies CBD American Shaman's commitment to consistent product safety and quality standards across all topical formulas in the product line. Publicly accessible lab results through the CBD American Shaman website allow any consumer to verify the full-spectrum cannabinoid breakdown and safety screening outcomes of a specific batch before or after purchase. Testing screens for pesticides, mold, heavy metals, and residual processing solvents that present direct risks when concentrated hemp compounds make repeated contact with the skin surface during each application. Independent verification of the full spectrum cannabinoid content, including trace THC at or below 0.3%, confirms regulatory compliance for every batch produced and distributed. Routine third-party screening ensures each 1-oz container delivers the labeled 1,000 mg of full spectrum nano cannabinoids alongside a verified and documented safety profile per independent laboratory confirmation.
A Certificate of Analysis (COA) is a formal document produced by an independent laboratory that verifies the cannabinoid content, full-spectrum plant profile, and safety screening results for a specific production batch of the Signature Collection Topical Cream. The COA Certificate of Analysis for the Signature Collection Topical Cream documents the exact concentration of CBD, CBDA, CBG, CBGA, and other full-spectrum cannabinoids retained through R134a extraction at the 1,000 mg total level per 1 oz container. Safety sections within the document list completed screening results for heavy metals, pesticides, residual solvents, and microbial contaminants that affect the integrity of the cream upon direct and repeated skin contact. Every COA carries a batch number that matches the lot number printed on the physical cream container for complete product-level traceability and consumer accountability per purchase. Consumers access these documents through the CBD American Shaman website to confirm the potency and safety profile of the cream before and after each purchase decision. The COA serves as the primary document confirming that the full-spectrum nano cannabinoid content meets all labeled and regulatory standards as an external hemp topical product. A complete Certificate of Analysis includes passing scores across every required safety category alongside the full cannabinoid and terpene profile associated with that specific production run.
This information is provided for educational purposes only. Cannabis laws vary significantly by jurisdiction.